CIK 0001819411 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Gain Therapeutics, Inc.
Sign in to watch- Ticker
- GANX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851726310
- Phone
- (301) 500-1556
- Business address
- 4800 HAMPDEN LANE, SUITE 200, BETHESDA, MD, 20814
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-29 | Weidner Jeanette See Remarks | Grant or award · Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2026-07-15 | GOLDSTEIN DOV A MD Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2026-07-15 | Nicaise Claude Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2026-07-15 | Islam Khalid Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2026-07-15 | Melincoff Gwen A Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2026-07-15 | Riley Jeffrey Scott Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2026-07-15 | HASLER HANS PETER Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2026-03-24 | Mack Gene CEO, President | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2026-03-24 | Fuggetta Gianluca See Remark | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-06-24 | Islam Khalid Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2025-06-24 | Riley Jeffrey Scott Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2025-06-24 | HASLER HANS PETER Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2025-06-24 | Melincoff Gwen A Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2025-06-24 | RICHMAN ERIC I Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2025-06-24 | GOLDSTEIN DOV A MD Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2025-06-24 | Nicaise Claude Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2025-03-20 | Fuggetta Gianluca See Remark | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-03-20 | Mack Gene CEO, President | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2025-01-06 | Mack Gene CEO, President | Grant or award · Stock Option (right to buy) | +271,325 | 271,325 | ||
| 2024-08-09 | Mack Gene CFO and Interim CEO | Purchase | +14,400 | $1.01 | $15K | 14,400 |
Page 1 of 5 · 88 trades